Loading prices…
🩸BEARISH

SEC halts Nasdaq BTC options listing amid CME jurisdictional dispute

The dispute is not about QBTC alone: CME argues that securities exchanges cannot list derivatives on commodities, and a ruling for CME could force every cash-settled crypto index product back through…

SEC halts Nasdaq BTC options listing amid CME jurisdictional dispute
SEC halts Nasdaq BTC options listing amid CME jurisdictional dispute
SEC halts Nasdaq BTC options listing amid CME jurisdictional dispute
SEC halts Nasdaq BTC options listing amid CME jurisdictional dispute

The Securities and Exchange Commission has paused Nasdaq's approval of cash-settled bitcoin index options and will reconsider the decision following a legal challenge from CME Group, the agency said in an order released for public inspection on July 31. Back in May, the SEC had granted Nasdaq PHLX conditional approval to list the product, which trades under the ticker QBTC and still required exemptions from the Commodity Futures Trading Commission before launch.

CME Group filed notice of its challenge on June 11, arguing that bitcoin is a commodity and that options tied directly to its value fall under the CFTC's exclusive jurisdiction rather than the SEC's. The stay has been in place since that filing, and QBTC remains suspended while the full commission reconsiders the May approval.

Why it matters

The argument is jurisdictional, not commercial. CME already operates a regulated bitcoin futures and options complex, and it warned that allowing Nasdaq to list a competing cash-settled product under SEC authority would set a precedent letting securities exchanges list derivatives on any commodity without registering under the CFTC framework. If CME prevails, Nasdaq would either need to register as a CFTC-regulated venue or redesign QBTC to track a security such as a spot bitcoin ETF rather than a commodity benchmark. The contract currently uses CME CF benchmarks for both its underlying index and final settlement price.

Market impact

The order keeps the approval frozen and gives interested parties until Aug. 24 to submit statements supporting or opposing it. CME also argued that the agencies cannot use exemptions to transfer a product from one regulator to another, undercutting the SEC's May vision of a path where the CFTC would grant exemptions to let Nasdaq and the Options Clearing Corporation offer QBTC through the securities market. The structural read is that every pending cash-settled crypto index product on a US securities venue is now in legal limbo until the commission clarifies where the line between CFTC and SEC authority actually sits.

Related tokens
$BTC

Frequently asked questions

  1. What is Nasdaq's QBTC bitcoin index options product?

    QBTC is a cash-settled bitcoin index option that Nasdaq PHLX received conditional SEC approval to list in May. It still required CFTC exemptions before launch and uses CME CF benchmarks for its underlying index and final settlement price.

  2. Why did CME Group challenge the SEC's approval of QBTC?

    CME argued that bitcoin is a commodity and that options tied to its value fall under the CFTC's exclusive jurisdiction, not the SEC's. It warned that allowing Nasdaq to list the product would set a precedent letting securities exchanges list derivatives on any commodity without registering under the CFTC framework.

  3. What happens to QBTC if CME wins the jurisdictional dispute?

    Nasdaq would need to either register as a CFTC-regulated futures or swaps venue or redesign QBTC to track a security such as a spot bitcoin ETF rather than a commodity benchmark. CME also argues the agencies cannot use exemptions to transfer the product from one regulator to another.

  4. When does the SEC reopen comments on the Nasdaq bitcoin options decision?

    The SEC's July 31 order keeps the approval frozen and gives interested parties until Aug. 24 to submit statements supporting or opposing the reconsideration.

  5. Could this dispute affect other cash-settled crypto index products?

    Yes. A ruling for CME would clarify that securities exchanges cannot list derivatives on commodities without CFTC oversight, potentially placing every pending cash-settled crypto index product on a US securities venue into legal limbo.

Source attribution
Aggregated from CoinDesk · Verified · Last refreshed 1h ago
Open original →